iPSC Working Group

iPSC Working Group Members
are listed here

The purpose of the Induced Pluripotent Stem Cells (iPSC) Working Group is to foster the development of scientific collaborations, knowledge transfer and capacity building activities.

Induced pluripotent stem cells derived from human fibroblasts using viral constructs for KLF4, c-Myc, OCT4 and SOX2.
Source: Patrick Lewis (p.lewis@ion.ucl.ac.uk)

Japan Science and Technology Agency visit / iPSC Road Map

The UCL Centre for Stem Cells and Regenerative Medicine hosted a visit from a delegation from the Japan Science and Technology Agency, a major funding organisation related to the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), on 25 January 2010.

Members may download the agenda from the meeting.

New iPSC collaboration funded by the NIHR programme in Molecular and Tissue Engineering

Prof Amit Nathwani Prof Peter Coffey A new collaboration developed as a result of the iPSC Working Group led to a new project, which was funded by the NIHR programme in Molecular and Tissue Engineering.  The project, focused on the development of induced pluripotent stem (iPS) cells for the treatment of age related macular degeneration, is led by Dr. Amit Nathwani (UCL Cancer Institute) and Prof. Pete Coffey (UCL Institute of Ophthalmology). 

 Previous Meetings of the iPSC Working Group

For papers and reports from previous iPSC Working Group meetings, click on the links below.

Meeting held on:

  • Tuesday 15 May 2012

This meeting focused on new tools and technologies for human cell fate reprogramming

  • Thursday 15 March 2012

This meeting was convened to discuss high quality iPSC resources, ongoing intiaitves and developments in the field

  • Tuesday 8 November 2011

This meeting was convened to discuss facilities for derivation of patient-specific iPSC

  • Wednesday 29 June 2011 

This meeting focused on new tools and technologies for reprogramming and for culturing pluripotent stem cells.

  • Thursday 25 November, 2010
    This meeting included a presentation "Modeling Parkinson's disease with iPS derived neuronal cells" by Dr. Patrick Lewis, UCL Institute of Neurology
  • Tuesday 2 March 2010
  • Wednesday 16 September 2009
    This meeting included a Special Lecture “Derivation of ocular cells using human embryonic stem cells and induced pluripotent stem cells” by Dr. Dennis Clegg, Co-Director, UCSB Center for Stem Cell Biology & Engineering, University of California, Santa Barbara, USA
  • Thursday 12 March 2009
  • Friday 30 January 2009

Page last modified on 16 may 12 09:28